Showing results for "Axon"
industries
Boston Scientific, Axonics Facing FTC Scrutiny Over Merging Urology TreatmentsBoston Scientific Corp.’s proposed $3.7 billion acquisition of medical device maker Axonics Inc. will likely be scrutinized by the US Federal Trade Commission because the companies are the dominant providers of some treatments for urinary incontinence, according to antitrust experts.March 7, 2024